• Investment World
• eWorld
• Catalyst
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources

Group Sites

• The Hindu
• Business Line
• The Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

Mumbai , Jan. 20

GLENMARK Pharmaceuticals Ltd has raised $30 million through the issue of Foreign Currency Convertible Bonds (FCCBs) to international investors, the company told the Bombay Stock Exchange.

Meanwhile, the company's board has also taken on record the exclusion of Mr Mark Saldanha and Mrs Sandra Saldanha from promoters of the company following the separation of businesses. Mr Mark Saldanha and his family will no longer be considered as promoters of the company within the meaning of the provisions of SEBI Takeover Regulations, 1992, the listing Agreement of the Stock Exchanges or any other regulation in force with regard to the same, Glenmark Pharma told the BSE.

More Stories on : Overseas Borrowings

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
More layoffs in Facor

Copyright © 2006, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line